Diagnostic Test Accuracy Protocol

You have free access to this content

APOE-ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a primary care setting

  1. Lyzel S Elias-Sonnenschein1,*,
  2. Wolfgang Viechtbauer2,
  3. Inez Ramakers1,
  4. Obioha Ukoumunne3,
  5. Frans RJ Verhey1,
  6. Pieter Jelle Visser1,4

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 31 JAN 2014

Assessed as up-to-date: 27 JAN 2014

DOI: 10.1002/14651858.CD010949


How to Cite

Elias-Sonnenschein LS, Viechtbauer W, Ramakers I, Ukoumunne O, Verhey FRJ, Visser PJ. APOE-ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a primary care setting (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No.: CD010949. DOI: 10.1002/14651858.CD010949.

Author Information

  1. 1

    Maastricht University, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht, Netherlands

  2. 2

    Maastricht University, Department of Psychiatry and Neuropsychology, Maastricht, Netherlands

  3. 3

    University of Exeter Medical School, University of Exeter, Peninsula CLAHRC, Exeter, Devon, UK

  4. 4

    VU University Medical Centre, Department of Neurology, Amsterdam, Netherlands

*Lyzel S Elias-Sonnenschein, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Postbus 616, Maastricht, 6200 MD, Netherlands. lyzel.elias@yahoo.nl.

Publication History

  1. Publication Status: New
  2. Published Online: 31 JAN 2014

SEARCH

References

Additional references

American Psychiatric Association 1987
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM III-R). Diagnostic and statistical manual of mental disorders (DSM III-R). Third Edition. Washington, DC: APA, 1987.
American Psychiatric Association 1994
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). Diagnostic and statistical manual of mental disorders (DSM-IV). Fourth. Washington, DC: APA, 1994.
American Psychiatric Association 2000
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM IV-TR). Fourth edition text revised. Washington: APA, 2000.
Bennett 2002
  • Bennett D, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, et al. Natural history of mild cognitive impairment in older persons. Neurology 2002;59:198-205.
Bertram 2007
  • Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nature Genetics 2007; Vol. 39, issue 1:17-23. [: http://www.alzgene.org]
Blennow 2006
Bossuyt 2003
  • Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis PP, Glasziou PP, Irwig LM, et al. Standards for reporting of diagnostic accuracy. Toward complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003;326:41-4.
Bossuyt 2008
  • Bossuyt PM, Leeflang MM. Chapter 6: Developing criteria for including studies. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.4. The Cochrane Collaboration, 2008.
Boxer 2005
Bu 2009
Dubois 2007
  • Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurology 2007;6:734-46.
Elias-Sonnenschein 2011
  • Elias-Sonnenschein LS, Viechtbauer W, Ramakers IHGB, Verhey RJ, Visser PJ. Predictive value of APOE-ε4 allele for conversion from MCI to AD-type dementia: a meta-analysis. Journal of Neurology, Neurosurgery, and Psychiatry 2011;10:1149-56.
Farrer 1997
  • Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 1997;278(16):1349-56.
Geslani 2005
  • Geslani DM, Tierney MC, Herrmann N. Mild Cognitive Impairment: An operational definition and its conversion rate to Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders 2005;19:383–9.
Ghebranious 2005
  • Ghebranious N, Ivacic L, Mallum J, Dokken C. Detection of ApoE E2, E3 and E4 alleles using the MALDI-TOF mass spectrometry and the homogeneous mass-extended technology. Nucleic Acids Research 2005;33(17):e149.
Glanville 2012
  • Glanville JM, Cikalo M, Crawford F, Dozier M, McIntosh H. Handsearching did not yield additional unique FDG-PET diagnostic test accuracy studies compared with electronic searches: a preliminary investigation. Research Synthesis Methods 2012;3:202-13.
Greenhalgh 2005
Hollingworth 2011
  • Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nature Genetics 2011;43(5):429-35.
Horsley 2011
Lambert 2009
  • Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nature Genetics 2009;41(10):1094-9.
Leoni 2011
  • Leoni V. The Effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease. Clinical Chemistry and Laboratory Medicine 2011;49(3):375-83.
Lunn 2009
Macaskill 2010
  • Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y. Chapter 10: Analysing and presenting results. In: Deeks JJ, Bossuyt PM, Gatsonis C editor(s). Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0. The Cochrane Collaboration, 2010. [: http://srdta.cochrane.org]
Matthews 2008
McKeith 2005
McKhann 1984
  • McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34(7):939-44.
McKhann 2011
  • McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia 2011;7:263-9.
Morris 2001
Murayama 2004
Naj 2011
  • Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, et al. Common variants at MS4A4A/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature Genetics 2011;43(5):436-41.
NICE 2006
  • National Institute for Health and Clinical Excellence. Dementia: supporting people with dementia and their careers in health and social care. Clinical Guideline 42. 2006.
Norberg 2011
  • Norberg J, Graff C, Almkvist O, Ewers M, Frisoni GB, Frölich L, et al. Regional differences in effects of APOE ɛ4 on cognitive impairment in non-demented subjects. Dementia and Geriatric Cognitive Disorders 2011;32:135-42.
Okello 2009
  • Okello A, Koivunen J, Edison P, Archer HA, Turkheimer FE, Någren K, et al. Conversion of amyloid positive and negative MCI to AD over 3 years. An 11C-PIB PET study. Neurology 2009;73(10):754-60.
Peters 2012
  • Peters O, Lorenz D, Fesche A, Schmidtke K, Hüll M, Perneczky R, et al. A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI. The Journal of Nutrition, Health & Aging 2012;16(6):544-8.
Petersen 2004
R Development Core Team 2009
  • R Development Core Team. A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, 2009.
Reitsma 2005
  • Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology 2005;58(10):982-90.
Review Manager 2012
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Roman 1993
  • Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43(2):250-60.
Rountree 2012
  • Rountree SD, Atri A, Lopez OL, Doody RS. Effectiveness of antidementia drugs in delaying Alzheimer disease progression. Alzheimer's & Dementia 2012;24:1-8. [doi: 10.1016/j.alz.2012.01.002]
Seshadri 2010
  • Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, et al. Genome-wide analysis of genetic loci associate with Alzheimer disease. JAMA 2010;303(18):1832-40.
Stata Corporation 2011
  • Stata Corporation. Stata/MP 11.2 for Macintosh. College Station, Texas: Stata Corporation, 2011.
Strittmatter 1993
  • Strittmatter WJ, Saunders AM, Schnechel D. Apolipoprotein E: High-avidity binding to b-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proceedings of the National Academy of Sciences 1993;90:1977-81.
The Lund and Manchester Groups 1994
  • The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. Journal of Neurology, Neurosurgery, and Psychiatry 1994;57:416-8.
Visser 2006
Whiting 2011
  • Whiting P, Rutjes A, Westwood M, Mallett S, Deeks J, Reitsma J, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155:529-36.
World Health Organization 1993
  • World Health Organization. International Statistical Classification of Diseases and Related Health Problems. International Statistical Classification of Diseases and Related Health Problems. 10th Edition. WHO, 1993.
World Health Organization 2012
  • World Health Organization. Dementia a public health priority. Dementia a public health priority. Geneva, Switzerland: World Health Organization, 2012.